Open Beta
TREN
MetriLume
TREN

US marketsSCNI

SEC-sourced researchBeta

SCNI

Scinai Immunotherapeutics Ltd.

Company comparison ↗

Data passport

CIK
0001611747
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
5/6
Filing date
Oct 5, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: — USD; December 2024: 658,000.0000 USD; December 2025: 1,311,000.0000 USD1.3M USD0 USD0December 2023December 2024December 2025
SCNI · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023No dataApr 1, 2026
December 2024658,000.0000Apr 1, 2026
December 20251,311,000.0000Apr 1, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20251,311,000.0000-8,307,000.0000-6,031,000.000011,626,000.0000—Apr 1, 2026
December 2024658,000.00004,796,000.0000-6,335,000.000013,448,000.0000—Apr 1, 2026
December 2023—-6,500,000.0000-9,382,000.0000——Apr 1, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$1.31MDecember 2025Apr 1, 202620-F
Previous period revenueRevenues$658KDecember 2024Apr 1, 202620-F
Net incomeNetIncomeLoss-$8.31MDecember 2025Apr 1, 202620-F
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$6.03MDecember 2025Apr 1, 202620-F
Total assetsAssets$11.63MDecember 2025Apr 1, 202620-F
Total liabilities————

New filings

Explore methodology ↗